31.1 C
New York
Saturday, June 13, 2026

Tag: LAW

newssourceFORcompanyinformationcontent1marketreleases

BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit with the Schall Law Firm

BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements

SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that on June 11, 2026 it has regained compliance with the Nasdaq Capital Markets Listing Requirements.

ING reduces its stake in TMBThanachart Bank

ING reduces its stake in TMBThanachart Bank

Shell announces pause in share buyback programme

Shell announces pause in share buyback programme

Cheche Group Announces Results of Extraordinary General Meeting

BEIJING, June 12, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced the...

Natural Grocers® Celebrates Arkansas Day with a Special Gift and Savings June 15-17, 2026

LAKEWOOD, Colo., June 12, 2026 /PRNewswire/ -- Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S., invites customers to its...

Fervo Energy to Report First Quarter 2026 Results on June 22, 2026

HOUSTON, June 12, 2026 (GLOBE NEWSWIRE) -- Fervo Energy Company (“Fervo” or the “Company”) (NASDAQ: FRVO), a leading technology-enabled independent power producer of Enhanced Geothermal Systems (EGS), today announced that it will release first quarter 2026 financial and operational results before the market opens on Monday, June 22, 2026. The Company will host a webcast and conference call that same day at 10:00 a.m. ET (9:00 a.m. CT) to discuss the results.

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2 Avail™ trial

$SEM Stock Drop Reminder: Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

Select Medical Announces $16.50 per share Acquisition – BFA Law’s Investigation into the Board is Ongoing

Arizona Metals Announces Filing of the NI 43-101 Technical Report for the Kay Mine Project Preliminary Economic Assessment

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR...

Transaction in Own Shares

Transaction in Own Shares

Binance Exchange Launches bStocks Tokenized Securities: 1:1 Backing and 24/7 Trading

ISLAMABAD, June 12, 2026 /PRNewswire/ -- Binance Exchange today announced the admission to trading of bStocks, fully-backed tokenized securities representing select U.S. stocks issued...

CBAK Energy Showcases Cylindrical Battery Solutions for Europe’s Expanding Energy Storage Market at The Battery Show Europe 2026

CBAK Energy showcased cylindrical battery solutions at The Battery Show Europe 2026, emphasizing safety, long cycle life, and compliance.

Evaxion receives Prix Galien UK Award for Best digital health solution

COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-Immunology™.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLAW

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers